InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,230.43
(
0.54%
)
Post# of 251706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

imnot6

Send PM Follow Ignore
Followers 3
Posts 848
Boards Moderated 0
Alias Born 11/28/2005

imnot6

Member Level

Re: jbog post# 199368

Friday, 02/05/2016 2:31:32 PM

Friday, February 05, 2016 2:31:32 PM

Post# of 251706
Related note: I've been seeing pharmacies approving Teva's Granix as a replacement agent for Neupogen with no mention of any exceptions, which puzzles me, because I though Granix in the US was only approved for chemo-induced neutropenia. Do pharmacy and therapeutic committees get to make "judgement calls" like that?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up